-
Hannah Cole
Latest listings
-
32D
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Established from long-term bone marrow cultures of C3H/HeJ mice infected with the Friend murine leukemia virus; cells are constitutively growth factor-dependent https://www.creative-bioarray.com/32D-CSC-C1101-item-1563.htm
-
WEHI 231
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C9260W Description Mineral oil induced tumor in (BALB/c x NZB)F1 mice Species Mus musculus (Mouse) Recommended Medium DMEM + 0.05mM 2-Mercaptoethanol (2ME) + 10% Foetal Bovine Serum (h.i.FBS). https://www.creative-bioarray.com/WEHI-231-CS...
-
Hepa 1-clc7
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Species: mouse, C57L; Tissue: liver; Tumor: hepatoma, BW7756; Derived from: Hepa-1cl, cloned from the Hepa-1 cell line https://www.creative-bioarray.com/Hepa-1-clc7-CSC-6264W-item-1508.htm
-
B16F10/mGM
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C6409J Description Mouse GM-CSF producing B16 melanoma. Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/b16f10-mgm-item-csc-c6409j-43009.htm
-
B16 F10
Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C9336L Description established from the skin of C57BL/6J mouse with B16 melanoma tumor Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/b16-f10-csc-c9336l-item-39483.htm
-
B16 BL6
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C9334L Description Histopathology: melanoma Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/B16-BL6-CSC-C9334L-item-39481.htm
-
ACA652 Probe
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. FBPC-53 Description The identification of microbes: Acinetobacter Size 50 Tests Usage For Research Use Only. Not for use in diagnostic procedures. Storage Store at minus 20 centigrade https://www.creative-bioarray.com/aca652-probe-item-fbpc-5...
-
RH-30
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Established from the bone marrow metastasis of a 17-year-old man with undifferentiated (standard classification) or unclassified (Palmer classification) alveolar rhabdomyosarcoma; cells were described as carrying a p53 mutation, expressing high level...
-
UKE-1
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C2301J Description established from peripheral blood of a 59-year-old woman with Essential thrombocythemia Species Homo sapiens (Human) Source Blood; Peripheral Blood Recommended Medium RPMI- 1640 with 2mM L-glutamine + 20% FBS https://ww...
-
IST-MES1
Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-6273W Description established from the pleural effusion of a 70- year- old Caucasian woman with pleural epithelioid mesothelioma Species Homo sapiens (Human) Source Pleural Effusion https://www.creative-bioarray.com/ist-mes1-csc-6273w-ite...











